|
Aug 29
|
Ironwood Pharmaceuticals to Participate in the 2024 Wells Fargo Healthcare Conference
|
|
Jul 25
|
Ironwood Pharmaceuticals to Host Second Quarter 2024 Investor Update Call
|
|
Jun 12
|
Insider Sale: Director Julie Mchugh Sells Shares of Ironwood Pharmaceuticals Inc (IRWD)
|
|
Feb 17
|
Ironwood Pharmaceuticals Full Year 2023 Earnings: EPS Misses Expectations
|
|
Feb 16
|
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Q4 2023 Earnings Call Transcript
|
|
Feb 16
|
Ironwood (IRWD) Q4 Earnings Miss, Revenues Beat Marginally
|
|
Feb 16
|
Q4 2023 Ironwood Pharmaceuticals Inc Earnings Call
|
|
Feb 15
|
Ironwood Pharmaceuticals (IRWD) Reports Break-Even Earnings for Q4
|
|
Feb 15
|
Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Results; Achieves 2023 Financial Guidance
|
|
Dec 5
|
Shareholders have faith in loss-making Ironwood Pharmaceuticals (NASDAQ:IRWD) as stock climbs 9.7% in past week, taking five-year gain to 2.3%
|
|
Nov 30
|
Stonegate Healthcare Partners Releases Report on Transformative Therapies for Pruritus Management
|
|
Oct 3
|
Ironwood Pharmaceuticals (IRWD): A Hidden Gem or a Potential Risk? An In-Depth Look at Its Valuation
|
|
Oct 1
|
Here's How to Lock in a Trade on a Promising Biopharma Name
|
|
Aug 9
|
Ironwood's (IRWD) Reports Q2 Loss, Linzess Volume Rises
|
|
Aug 9
|
Q2 2023 Ironwood Pharmaceuticals Inc Earnings Call
|
|
Aug 8
|
Ironwood Pharmaceuticals (IRWD) Q2 Earnings and Revenues Surpass Estimates
|
|
Aug 8
|
Ironwood Pharmaceuticals Reports Second Quarter 2023 Results; Raises Full Year 2023 LINZESS® U.S. Net Sales and Ironwood Revenue Guidance
|